About this trial
This multicenter study aims to evaluate whether active breast ultrasound screening can improve the early diagnosis rate of breast cancer in women aged 65 to 80 years, compared with routine elderly health management. The study uses a mixed cluster-individual randomized design based on community implementation capacity. A subgroup of pilot communities will simultaneously collect ultrasound AI data for research performance analysis only, without affecting clinical diagnosis.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
History of breast cancer Breast screening within past 2 years Severe comorbid conditions affecting survival Acute breast infection Cognitive impairment affecting participation
Trial design
Parallel
Treatments tested in this trial
Standardized Breast Ultrasound Screening
Procedure/SurgeryRetrospective AI image analysis for research use only, not involved in clinical decision-making.
Treatment groups
Trial outcomes
Primary outcomes
Absolute difference in early-stage breast cancer diagnosis rate
Proportion of pathologically confirmed breast cancer cases at stage I or stage II, compared between the ultrasound screening group and the routine management group within 2-year follow-up.
Secondary outcomes
Overall breast cancer detection rate
Overall breast cancer detection rate
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: